259 related articles for article (PubMed ID: 15109399)
1. Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats.
Xu L; Fagan SC; Waller JL; Edwards D; Borlongan CV; Zheng J; Hill WD; Feuerstein G; Hess DC
BMC Neurol; 2004 Apr; 4():7. PubMed ID: 15109399
[TBL] [Abstract][Full Text] [Related]
2. Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model.
Pei Z; Pang SF; Cheung RT
Stroke; 2003 Mar; 34(3):770-5. PubMed ID: 12624306
[TBL] [Abstract][Full Text] [Related]
3. Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat.
Reglodi D; Somogyvari-Vigh A; Vigh S; Kozicz T; Arimura A
Stroke; 2000 Jun; 31(6):1411-7. PubMed ID: 10835464
[TBL] [Abstract][Full Text] [Related]
4. Delayed neuroprotective effect of insulin-like growth factor-i after experimental transient focal cerebral ischemia monitored with mri.
Schäbitz WR; Hoffmann TT; Heiland S; Kollmar R; Bardutzky J; Sommer C; Schwab S
Stroke; 2001 May; 32(5):1226-33. PubMed ID: 11340238
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats.
Belayev L; Khoutorova L; Deisher TA; Belayev A; Busto R; Zhang Y; Zhao W; Ginsberg MD
Stroke; 2003 Mar; 34(3):758-63. PubMed ID: 12624304
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor-18 reduced infarct volumes and behavioral deficits after transient occlusion of the middle cerebral artery in rats.
Ellsworth JL; Garcia R; Yu J; Kindy MS
Stroke; 2003 Jun; 34(6):1507-12. PubMed ID: 12738892
[TBL] [Abstract][Full Text] [Related]
7. Prereperfusion saline infusion into ischemic territory reduces inflammatory injury after transient middle cerebral artery occlusion in rats.
Ding Y; Li J; Rafols JA; Phillis JW; Diaz FG
Stroke; 2002 Oct; 33(10):2492-8. PubMed ID: 12364743
[TBL] [Abstract][Full Text] [Related]
8. Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat.
Candelario-Jalil E; González-Falcón A; García-Cabrera M; León OS; Fiebich BL
Brain Res; 2004 May; 1007(1-2):98-108. PubMed ID: 15064140
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection by the stable nitroxide 3-carbamoyl-proxyl during reperfusion in a rat model of transient focal ischemia.
Hu G; Lyeth BG; Zhao X; Mitchell JB; Watson JC
J Neurosurg; 2003 Feb; 98(2):393-6. PubMed ID: 12593628
[TBL] [Abstract][Full Text] [Related]
10. MCP-induced protein 1 mediates the minocycline-induced neuroprotection against cerebral ischemia/reperfusion injury in vitro and in vivo.
Jin Z; Liang J; Wang J; Kolattukudy PE
J Neuroinflammation; 2015 Feb; 12():39. PubMed ID: 25888869
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective properties of the non-peptidyl radical scavenger IAC in rats following transient focal cerebral ischemia.
Nurmi A; Miettinen TK; Puoliväli J; Pussinen R; Soleti A; Bagate K; Riccardino F; Grundy RI; Yrjänheikki J; Canistro D; Paolini M
Brain Res; 2008 May; 1207():174-81. PubMed ID: 18374313
[TBL] [Abstract][Full Text] [Related]
12. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window.
Belayev L; Liu Y; Zhao W; Busto R; Ginsberg MD
Stroke; 2001 Feb; 32(2):553-60. PubMed ID: 11157196
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotection by pyrroloquinoline quinone (PQQ) in reversible middle cerebral artery occlusion in the adult rat.
Zhang Y; Feustel PJ; Kimelberg HK
Brain Res; 2006 Jun; 1094(1):200-6. PubMed ID: 16709402
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of endothelin type A receptor antagonist on brain edema and injury after transient middle cerebral artery occlusion in rats.
Matsuo Y; Mihara Si ; Ninomiya M; Fujimoto M
Stroke; 2001 Sep; 32(9):2143-8. PubMed ID: 11546909
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effect of CGS 26303, an endothelin-converting enzyme inhibitor, on transient middle cerebral artery occlusion in rats.
Chang CZ; Yen CP; Winadi D; Wu SC; Howng SL; Lin TK; Jeng AY; Kassell NF; Kwan AL
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S487-9. PubMed ID: 15838355
[TBL] [Abstract][Full Text] [Related]
16. A glycine site antagonist, ZD9379, reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion.
Tatlisumak T; Takano K; Meiler MR; Fisher M
Stroke; 1998 Jan; 29(1):190-5. PubMed ID: 9445350
[TBL] [Abstract][Full Text] [Related]
17. In vivo neuroprotective effects of ACEA 1021 confirmed by magnetic resonance imaging in ischemic stroke.
Petty MA; Neumann-Haefelin C; Kalisch J; Sarhan S; Wettstein JG; Juretschke HP
Eur J Pharmacol; 2003 Aug; 474(1):53-62. PubMed ID: 12909195
[TBL] [Abstract][Full Text] [Related]
18. Preischemic neuroprotective effect of minocycline and sodium ozagrel on transient cerebral ischemic rat model.
Park SI; Park SK; Jang KS; Han YM; Kim CH; Oh SJ
Brain Res; 2015 Mar; 1599():85-92. PubMed ID: 25555371
[TBL] [Abstract][Full Text] [Related]
19. Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke.
Khan M; Sekhon B; Jatana M; Giri S; Gilg AG; Sekhon C; Singh I; Singh AK
J Neurosci Res; 2004 May; 76(4):519-27. PubMed ID: 15114624
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
